09:19 AM EDT, 09/30/2025 (MT Newswires) -- Health care stocks were flat to lower pre-bell Tuesday, with the iShares Biotechnology ETF (IBB) inactive and The Health Care Select Sector SPDR Fund ( XLV ) down 0.2%.

Novo Nordisk's ( NVO ) type 2 diabetes treatment Ozempic is now available through LifeMD ( LFMD ) at $499 per month, LifeMD ( LFMD ) said. Shares of Novo Nordisk ( NVO ) were down more than 2% premarket.

Nanobiotix ( NBTX ) shares were up nearly 7% after the company said updated data from a phase 1 trial evaluating JNJ-1900 in patients with recurrent and/or metastatic head and neck squamous cell carcinoma demonstrated "early efficacy signals" and a well-tolerated safety profile.

Faraday Future Intelligent Electric ( FFAI ) said the $41 million investment in Qualigen Therapeutics ( QLGN ) has closed. Qualigen Therapeutics ( QLGN ) shares were up more than 6% pre-bell.